Masimo (NSDQ:MASI) said yesterday it is renewing a $1 million challenge made originally in 2013 that its SET pulse oximeter will outperform its device equivalent from competitor Nellcor, now owned by Medtronic (NYSE:MDT). If a hospital can prove in a head-to-head comparison that Masimo’s SET pulse oximeter is inferior to Nellcor’s device, Irvine, Calif.-based Masimo will pay […]
Covidien
Medtronic touts 1-year data for VenaSeal device
Medtronic (NYSE:MDT) today touted results from its VeClose clinical trial of its VenaSeal varicose vein treatment, saying the device posted a 96.8% closure rate at 12 months. Results from the study were presented by principal investigator Dr. Nick Morrison of the Morrison Vein Institute in Scottsdale, Ariz., at the the European Venous Forum 2015 in St. Petersburg, Russia. VenaSeal […]
Medtronic’s Q4 sales surge 60% on Covidien buy, outlook narrowed
Whistleblowing ex-Covidien rep sues for wrongful termination
A former sales rep for Covidien‘s vascular business accused the company of wrongful termination after it fired him for blowing the whistle to the FBI on an alleged kickbacks scheme.